[e-farmacos] WHO Pharmaceuticals Newsletter n3 del 2004

["Canas, Martin" <macanas@netverk.com.ar>]

Esta disponible en la red el WHO Pharmaceuticals Newsletter n3 del 2004
cuyo indice es:


REGULATORY MATTERS

ARIPIPRAZOLE, CLOZAPINE, QUETIAPINE AND

OTHER ATYPICAL ANTIPSYCHOTICS -- Label to indicate risk of hyperglycaemia and diabetes... 1

MUROMONAB-CD3 -- Serious adverse reactions in paediatric patients... 1

NU BAO -- Presence of animal derivatives and human tissue poses health risks... 1

OTC DRUGS -- New labelling rules to increase safety ... 2

SHITEK TONGKAT ALI PLUS 400MG -- Presence of tadalafil ... 2

TOLCAPONE -- Marketing re-authorized, but more stringent monitoring recommended ... 2

TRAZODONE -- Interactions with CYP3A4 inhibitors/inducers ... 2

SAFETY OF MEDICINES
CARVEDILOL -- Reports of diarrhoea...4

CYCLO-OXYGENASE-2 INHIBITORS -- Reports of visual disturbances ... 4

FURANOCOUMARINS -- Presence in a herbal reparation... 4

LEFLUNOMIDE -- Awareness and monitoring can reduce the impact of adverse
effects ... 5

OXANDROLONE -- Warning for interaction with warfarin... 5

SHUBAO SLIMMING CAPSULES -- Presence of fenfluramine and
nitrosofenfluramine... 5

STATINS -- Important to measure creatine kinase levels ... 6

TEGASEROD -- Warning about diarrhoea and ischaemic colitis ... 6

THIOMERSAL IN VACCINES -- Recent evidence supports ... 6

ZAFIRLUKAST -- Reports of serious hepatic events ...7

La direccion es:
http://www.who.int/medicines/library/pnewslet/3news2004.pdf

Saludos,

Martin

Martin Canas
La Plata
(Argentina)
macanas@netverk.com.ar